TCL Archive ODAC Vote On CPT-11 Changes Standard Of Care For Advanced Colorectal Cancer. March 24, 2000
TCL Archive Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies April 26, 2013
TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007